ISEE - IVERIC bio Inc
Close
39.95
0.150 0.375%
Share volume: 0
Last Updated: Mon 10 Jul 2023 10:00:00 PM CEST
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$39.80
0.15
0.38%
Fundamental analysis
38%
Profitability
45%
Dept financing
5%
Liquidity
50%
Performance
37%
Performance
5 Days
0 0%
1 Month
0 0%
3 Months
0 0%
6 Months
0 0%
1 Year
0 0%
2 Year
0 0%
Key data
Company detail
CEO: Glenn Sblendorio
Region: US
Website: https://ivericbio.com/
Employees: 0
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Preparation Manufacturing
Sector: Manufacturing
Region: US
Website: https://ivericbio.com/
Employees: 0
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Preparation Manufacturing
Sector: Manufacturing
we are a biopharmaceutical company specializing in the development of novel therapeutics to treat diseases of the back of the eye, with a focus on developing therapeutics for age-related macular degeneration (amd).
Recent news